Page 114 - Cardiac Nursing

96.
8:4
009
M
1 A
9-0
9/2
P
g
p06
9/0
qxd
0
K34
0-c
03_
L L LWB K34 0-c 03_ p06 9-0 96. qxd 0 9/0 9/2 009 0 0 8:4 1 A M P a a g e 9 0 A pta ra
LWB
LWBK340-c03_p069-096.qxd 09/09/2009 08:41 AM Page 90 Aptara
e 9
0 A
pta
ra
90 PA R T I / Anatomy and Physiology
5. Kincaid, K., Ward, M., Nair, U., et al. (2005). The coronary baroreflex Bezold-Jarisch reflex during resuscitation from hemorrhage. Journal of
in humans. Journal of Extracorporeal Technology, 37, 306–310. Trauma, 63, 26–32.
7
7
6. Wright, C., Drinkhill, M. J., & Hainsworth, R. (2000). Reflex effects of 29. Hlastala, M., & Berger, A. (2001). Physiology of respiration. New York:
independent stimulation of coronary and left ventricular mechanorecep- Oxford University Press.
tors in anaesthetised dogs. Journal of Physiology (London), 528(Pt. 2), 30. Kara, T., Narkiewicz, K., & Somers, V. K. (2003). Chemoreflexes—
349–358. physiology and clinical implications. Acta Physiologica Scandinavica,
7
7
7. Wright, C. I., Drinkhill, M. J., & Hainsworth, R. (2001). Responses to 177, 377–384.
stimulation of coronary and carotid baroreceptors and the coronary 31. Floras, J. S. (2008). Hypertension, sleep apnea, and atherosclerosis. Hy-
chemoreflex at different ventricular distending pressures in anaesthetised pertension, from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd
6
6
dogs. Experimental Physiology, 86, 381–390. Retrieve&db PubMed&dopt Citation&list_uids 19015398.
8. Dampney, R. A., Horiuchi, J., Killinger, S., et al. (2005). Long-term reg- 32. Narkiewicz, K., & Somers, V. K. (2003). Sympathetic nerve activity in
7
ulation of arterial blood pressure by hypothalamic nuclei: Some critical obstructive sleep apnoea. Acta Physiologica Scandinavica, 177, 385–390.
7
questions. Clinical and Experimental Pharmacology and Physiology, 32, 33. Javaheri, S. (1996). Central sleep apnea-hypopnea syndrome in heart
419–425. failure: Prevalence, impact, and treatment. Sleep, 19, S229–S231.
9. Fenton, A. M., Hammill, S. C., Rea, R. F., et al. (2000). Vasovagal syn- 34. Floras, J. S. (2008). Should sleep apnoea be a specific target of therapy
cope. Annals of Internal Medicine, 133, 714–725. in heart failure? Heart, from http://www.ncbi.nlm.nih.gov/entrez/
10. Aviado, D. M., & Guevara Aviado, D. (2001). The Bezold-Jarisch reflex. query.fcgi?cmd Retrieve&db PubMed&dopt Citation&list_uids
A historical perspective of cardiopulmonary reflexes. Annals of the New 19029172.
York Academy of Science, 940, 48–58. 35. Somers, V. K., White, D. P., Amin, R., et al. (2008). Sleep apnea and car-
11. Grubb, B. P. (2005). Clinical practice. Neurocardiogenic syncope. New diovascular disease: An American Heart Association/American College
England Journal of Medicine, 352, 1004–1010. Of Cardiology Foundation Scientific Statement from the American
12. Serrano, C. V., Jr., Bortolotto, L. A., Cesar, L. A., et al. (1999). Sinus Heart Association Council for High Blood Pressure Research Profes-
bradycardia as a predictor of right coronary artery occlusion in patients sional Education Committee, Council on Clinical Cardiology, Stroke
with inferior myocardial infarction. International Journal of Cardiology, Council, and Council On Cardiovascular Nursing. In collaboration with
68, 75–82. the National Heart, Lung, and Blood Institute National Center on Sleep
13. Goldstein, J. A., Lee, D. T., Pica, M. C., et al. (2005). Patterns of coro- Disorders Research (National Institutes of Health). Circulation, 118,
nary compromise leading to bradyarrhythmias and hypotension in infe- 1080–1111.
6
rior myocardial infarction. Coronary Artery Disease, 16, 265–274. 36. Schmidt, H., Francis, D. P., Rauchhaus, M., et al. (2005). Chemo- and
6
14. Thoren, P. (1972). Left ventricular receptors activated by severe asphyxia ergoreflexes in health, disease and ageing. International Journal of Cardi-
and by coronary artery occlusion. Acta Physiologica Scandinavica, 85, ology, 98, 369–378.
455–463. 37. Dampney, R. A., Coleman, M. J., Fontes, M. A., et al. (2002). Central
15. Fu, L. W., Guo, Z. L., & Longhurst, J. C. (2008). Undiscovered role of mechanisms underlying short- and long-term regulation of the cardio-
endogenous thromboxane A2 in activation of cardiac sympathetic affer- vascular system. Clinical and Experimental Pharmacology and Physiology,
ents during ischaemia. Journal of Physiology, 586, 3287–3300. 29, 261–268.
6
6
16. Fu, L. W., Phan, A., & Longhurst, J. C. (2008). Myocardial ischemia- 38. Pilowsky, P. M., & Goodchild, A. K. (2002). Baroreceptor reflex pathways
mediated excitatory reflexes: A new function for thromboxane A2? and neurotransmitters: 10 years on. Journal of Hypertension, 20, 1675–1688.
0
American Journal of Physiology Heart and Circulatory Physiology, 295(6), 39. Stocker, S. D., Osborn, J. L., & Carmichael, S. P. (2008). Forebrain os-
H2530–H2540. motic regulation of the sympathetic nervous system. Clinical and Exper-
17. Longhurst, J. C., Tjen, A. L. S. C., & Fu, L. W. (2001). Cardiac sym- imental Pharmacology and Physiology, 35, 695–700.
pathetic afferent activation provoked by myocardial ischemia and reper- 40. Coote, J. H. (2007). Landmarks in understanding the central nervous
fusion. Mechanisms and reflexes. Annals of the New York Academy of control of the cardiovascular system. Experimental Physiology, 92, 3–18.
Science, 940, 74–95. 41. Helke, C. J., & Seagard, J. L. (2004). Substance P in the baroreceptor
18. Chiladakis, J. A., Patsouras, N., & Manolis, A. S. (2003). The Bezold- reflex: 25 years. Peptides, 25, 413–423.
Jarisch reflex in acute inferior myocardial infarction: Clinical and sym- 42. Grassi, G., Trevano, F. Q., Seravalle, G., et al. (2006). Baroreflex func-
6
6
pathovagal spectral correlates. Clinical Cardiology, 26, 323–328. tion in hypertension: Consequences for antihypertensive therapy.
19. Perez-Gomez, F., & Garcia-Aguada, A. (1977). Origin of ventricular re- Progress in Cardiovascular Disease, 48, 407–415.
flexes caused by coronary arteriography. British Heart Journal, 39, 43. Bylund, D. B., Eikenberg, D. C., Hieble, J. P., et al. (1994). Interna-
967–973. tional Union of Pharmacology nomenclature of adrenoceptors. Pharma-
20. Mark, A. L., Kioschos, J. M., Abboud, F. M., et al. (1973). Abnormal cology in Review, 46, 121–136.
6
6
vascular responses to exercise in patients with aortic stenosis. Journal of 44. Lands, A. M., Arnold, A., McAuliff, J. P., et al. (1967). Differentiation
Clinical Invest, 52, 1138–1146. of receptor systems activated by sympathomimetic amines. Nature, 214,
4
4
21. Mark, A., Abboud, F., Schmid, P., et al. (1973). Reflex vascular response 597–598.
to left ventricular outflow obstruction and activation of ventricular 45. Guimaraes, S., & Moura, D. (2001). Vascular adrenoceptors: An update.
baroreceptors in dogs. Journal of Clinical Investigations, 52, 1147–1153. Pharmacology in Review, 53, 319–356.
22. Mark, A., & Mancia, G. (1983). Cardiopulmonary baroreflexes in hu- 46. Civantos Calzada, B., & Aleixandre de Artinano, A. (20010. Alpha-
mans. In J. Sheperd & F. Abboud (Eds.), Handbook of physiology. Section adrenoceptor subtypes. Pharmacology Research, 44, 195–208.
4
4
2. The cardiovascular system (pp. 795–813). Bethesda, MD: American 47. Kable, J., Murrin, L., & Bylund, D. B. (2000). In vivo gene modifica-
Physiological Society. tion elucidates subtype-specific functions of alpha (2)-adrenergic recep-
23. Omran, H., Fehske, W., Rabahieh, R., et al. (1996). Valvular aortic tors. Journal of Pharmacology and Experimental Therapeutics, 293, 1–7.
stenosis: risk of syncope. Journal of Heart Valve Disease, 5, 31–34. 48. Kanagy, N. L. (2005). Alpha(2)-adrenergic receptor signalling in hyper-
24. Prasad, K., Williams, L., Campbell, R., et al. (2008). Episodic syncope tension. Clinical Science (London), 109, 431–437.
in hypertrophic cardiomyopathy: Evidence for inappropriate vasodila- 49. Leech, C. J., & Faber, J. E. (1996). Different alpha-adrenoceptor sub-
4
4
tion. Heart, 94, 1312–1317. types mediate constriction of arterioles and venules. American Journal of
25. Thaman, R., Elliott, P. M., Shah, J. S., et al. (2005). Reversal of inap- Physiology, 270, H710–H722.
propriate peripheral vascular responses in hypertrophic cardiomyopathy. 50. Banday, A. A., & Lokhandwala, M. F. (2008). Dopamine receptors and
6
Journal of the American College of Cardiology, 46, 883–892. hypertension. Current Hypertension Report, 10, 268–275.
6
26. Lim, P. O., Morris-Thurgood, J. A., & Frenneaux, M. P. (2002). Vascular 51. Missale, C., Nash, S. R., Robinson, S. W., et al. (1998). Dopamine re-
mechanisms of sudden death in hypertrophic cardiomyopathy, including ceptors: from structure to function. Physiology in Review, 78, 189–225.
blood pressure responses to exercise. Cardiology in Review, 10, 15–23. 52. Zeng, C., Armando, I., Luo, Y., et al. (2008). Dysregulation of
27. Lee, T. M., Chen, M. F., Su, S. F., et al. (1996). Excessive myocardial dopamine-dependent mechanisms as a determinant of hypertension:
contraction in vasovagal syncope demonstrated by echocardiography studies in dopamine receptor knockout mice. American Journal of Phys-
4
4
during head-up tilt test. Clinical Cardiology, 19, 137–140. iology Heart and Circulatory Physiology, 294, H551–H569.
28. Wisbach, G., Tobias, S., Woodman, R., et al. (2007). Preserving cardiac 53. Jose, P. A., Eisner, G. M., & Felder, R. A. (2003). Regulation of blood
output with beta-adrenergic receptor blockade and inhibiting the pressure by dopamine receptors. Nephron Physiology, 95, 19–27.